NASDAQ : DAVI
Davion Healthcare Plc — Financial statements
Healthcare · Medical Devices · Ireland
Last price 1.68 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 42.00M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in EUR.
| TTM | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Selling, General & Admin | 823.98K | 823.98K | 1.31M | 2.29M |
| Research & Development | 8.16K | 3.02M | ||
| Operating Expenses | 823.98K | 823.98K | 1.32M | 5.31M |
| Operating Income | -823.98K | -823.98K | -1.32M | -5.31M |
| Pretax Income | -823.98K | -823.98K | -1.32M | -5.31M |
| Net Income | -823.98K | -823.98K | -1.32M | -5.31M |
| Net Income to Common | -823.98K | -823.98K | -1.32M | -5.31M |
| Shares Outstanding (Basic) | 25.00M | 25.00M | 22.91M | 15.26M |
| Shares Outstanding (Diluted) | 25.00M | 25.00M | 22.91M | 15.26M |
| EPS (Basic) | -0.03 | -0.03 | -0.06 | -0.35 |
| EPS (Diluted) | -0.03 | -0.03 | -0.06 | -0.35 |
| EBIT | -823.98K | -823.98K | -1.32M | -5.31M |
Balance sheet
Fiscal year January - December; amounts in EUR.
| TTM | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Cash & Equivalents | 1.06K | 1.06K | 11.00 | 679.00 |
| Cash & Short-Term Investments | 1.06K | 1.06K | 11.00 | 679.00 |
| Other Receivables | 17.03K | 17.03K | 8.14K | 331.00 |
| Receivables | 17.03K | 17.03K | 8.14K | 331.00 |
| Other Current Assets | 122.51K | 122.51K | ||
| Total Current Assets | 140.60K | 140.60K | 8.15K | 1.01K |
| Other Intangible Assets | 65.00M | 65.00M | 65.00M | 65.00M |
| Total Assets | 65.14M | 65.14M | 65.01M | 65.00M |
| Accounts Payable | 17.17K | 17.17K | 2.95K | 257.00 |
| Accrued Expenses | 71.34K | 71.34K | 6.00K | |
| Other Current Liabilities | 30.80K | 600.00K | ||
| Total Current Liabilities | 88.51K | 88.51K | 39.76K | 600.26K |
| Long-Term Debt | 907.67K | 907.67K | 4.63M | |
| Total Liabilities | 996.18K | 996.18K | 39.76K | 5.23M |
| Common Stock | 250.00K | 250.00K | 250.00K | 200.00K |
| Additional Paid-In Capital | 71.35M | 71.35M | 71.35M | 64.88M |
| Retained Earnings | -7.45M | -7.45M | -6.63M | -5.31M |
| Shareholders' Equity | 64.14M | 64.14M | 64.97M | 59.77M |
| Total Liabilities & Equity | 65.14M | 65.14M | 65.01M | 65.00M |
| Total Debt | 907.67K | 907.67K | 4.63M | |
| Net Cash (Debt) | -906.61K | -906.61K | 11.00 | -4.63M |
| Net Cash Per Share | -0.04 | -0.04 | 0.00 | -0.30 |
| Filing Date Shares Outstanding | 25.00M | 25.00M | 25.00M | 15.26M |
| Total Common Shares Outstanding | 25.00M | 25.00M | 25.00M | 15.26M |
| Working Capital | 52.09K | 52.09K | -31.61K | -599.25K |
| Book Value Per Share | 2.57 | 2.57 | 2.60 | 3.92 |
| Tangible Book Value | -855.58K | -855.58K | -31.61K | -5.23M |
| Tangible Book Value Per Share | -0.03 | -0.03 | -0.00 | -0.34 |
Cash flow statement
Fiscal year January - December; amounts in EUR.
| TTM | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Net Income | -823.98K | -823.98K | -1.32M | -5.31M |
| Change in Accounts Payable | 48.76K | 48.76K | 436.58K | 600.26K |
| Change in Other Net Operating Assets | 774.90K | 774.90K | 883.11K | 4.71M |
| Operating Cash Flow | -323.00 | -323.00 | -668.00 | 679.00 |
| Long-Term Debt Issued | 1.37K | 1.37K | ||
| Net Debt Issued (Repaid) | 1.37K | 1.37K | ||
| Financing Cash Flow | 1.37K | 1.37K | ||
| Net Cash Flow | 1.05K | 1.05K | -668.00 | 679.00 |
| Levered Free Cash Flow | -597.63K | -597.63K | -1.39M | |
| Unlevered Free Cash Flow | -597.63K | -597.63K | -1.39M | |
| Change in Working Capital | 823.65K | 823.65K | 1.32M | 5.31M |
Ratios
Fiscal year January - December; amounts in EUR.
| TTM | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.08 | |
| Net Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.08 |
| Quick Ratio | 0.20 | 0.20 | 0.20 | 0.00 |
| Current Ratio | 1.59 | 1.59 | 0.20 | 0.00 |
| Return on Equity (ROE) | -1.28% | -1.28% | -2.12% | |
| Return on Assets (ROA) | -0.79% | -0.79% | -1.27% | |
| Return on Capital Employed (ROCE) | -1.30% | -1.30% | -2.00% | -8.20% |
| Buyback Yield / Dilution | -9.12% | -9.12% | -50.15% |